Your browser doesn't support javascript.
loading
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
Furuhashi, Masato; Tuncman, Gürol; Görgün, Cem Z; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R; Fazio, Sergio; Linton, MacRae F; Sulsky, Richard; Robl, Jeffrey A; Parker, Rex A; Hotamisligil, Gökhan S.
Affiliation
  • Furuhashi M; Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Nature ; 447(7147): 959-65, 2007 Jun 21.
Article in En | MEDLINE | ID: mdl-17554340

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Atherosclerosis / Fatty Acid-Binding Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2007 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Atherosclerosis / Fatty Acid-Binding Proteins Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2007 Document type: Article Affiliation country: United States Country of publication: United kingdom